NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
08/27/2024
Back to search
Official data from USPTO
DZS MEDFILES GLOBAL
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
DZS MEDFILES GLOBAL
ST13
US500000097436149Class
42
Filing
97436149
Registration
7484401
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
22
Latest update
08/27/2024
Trademark type
Word
Nice classes
42
Filing date
05/31/2022
Registration date
08/27/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/27/2024
Last transaction
08/27/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
03/01/2022
First use in commerce
03/01/2022
Drawing code
4
Owner type
03
Owner location
Monmouth Junction, NJ, US
Examiner
LEE, RAYMOND KANGMIN
Law office
N90
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
DZS Clinical Services, Inc.
Representatives
David E. Gray, Esq. GRAY LAW GROUP, LLC
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Biological research; Biological research and analysis; Chemicalbiochemicalbiological and bacteriological research and analysis; Scientific research in the field of Biological and clinical research; Clinical research in the field of pharmaceuticals; Clinical trials for others; medical and scientific research in the nature of pharmaceutical products; Conducting clinical trials for others; Conducting clinical trials for pharmaceutical products for others; Providing information about the results of clinical trials for pharmaceutical products; Providing scientific research information in the field of pharmaceuticals and clinical trials; Contract research services relating to molecular sciences; Technical data analysis services; Information technology services for the pharmaceutical industriesinformation technology consultancy relating to installationmaintenance and repair of computer software; Scientific risk assessment; Technical advice relating to pharmaceutical safety
Publications
History of USPTO decisions and trademark events.
22 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
08/27/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/11/2024
PUBO
PUBLISHED FOR OPPOSITION
06/11/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/22/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/08/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/08/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/08/2024
ALIE
ASSIGNED TO LIE
04/08/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/17/2023
NREV
NOTICE OF REVIVAL - E-MAILED
11/17/2023
PETG
PETITION TO REVIVE-GRANTED
11/17/2023
PROA
TEAS PETITION TO REVIVE RECEIVED
11/17/2023
MAB2
ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
09/05/2023
MAB2
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
09/05/2023
ABN2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
09/05/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
05/17/2023
GNRT
NON-FINAL ACTION E-MAILED
05/17/2023
CNRT
NON-FINAL ACTION WRITTEN
05/17/2023
DOCK
ASSIGNED TO EXAMINER
03/16/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/07/2022
NWAP
NEW APPLICATION ENTERED
06/03/2022
Continuous trademark protection
Get notified about every new filing that threatens DZS MEDFILES GLOBAL or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.